Taysha Gene Therapies, Inc. Balance Sheet

Balance Sheet Dec2022 Dec2023 Dec2024
Accumulated Depreciation 1.64M2.98M3.58M
Assets
Current Assets
Cash & Equivalents 87.88M143.94M139.04M
Receivables - Other 2.60M2.60M2.60M
Prepaid Assets 8.54M3.48M2.65M
Current Assets 96.42M149.87M142.13M
Non-Current Assets
Property, Plant & Equipment (Net) 14.96M10.83M7.49M
Other Non-Current Assets 2.64M2.60M2.15M
Non-Current Assets 29.86M22.86M18.23M
Assets 126.28M172.73M160.36M
Liabilities
Current Liabilities
Accounts Payables 10.95M6.37M3.59M
Payables 10.95M6.37M3.59M
Accumulated Expenses 18.29M12.28M12.86M
Other Accumulated Expenses 0.65M0.72M0.75M
Current Leases 1.52M1.65M1.88M
Current Deferred Revenue 33.56M18.11M9.80M
Total Current Liabilities 62.79M36.76M26.23M
Non-Current Liabilities
Non-Current Debt 37.97M40.51M43.94M
Operating Leases 20.44M18.95M17.36M
Other Non-Current Liabilities 4.13M1.58M1.31M
Total Non-Current Liabilities 121.20M96.22M87.53M
Total Liabilities 125.33M97.79M88.84M
Shareholder's Equity
Total Debt 37.97M40.51M43.94M
Common Equity 0.95M74.94M71.53M
Shareholder's Equity 0.95M74.94M71.53M
Liabilities and Shareholders Equity 126.28M172.73M160.36M
Retained Earnings -401.44M-513.01M-602.30M
Treasury Shares 1.26M0.38M4.55M